Chenicheri Hariharan Nair
Plus aucun poste en cours
Profil
Chenicheri Hariharan Nair served as a Non-Executive Deputy Chairman at Memphasys Ltd.
from 2012 to 2013.
He was also an Executive Chairman at PrIME Biologics Pte Ltd.
Additionally, he worked as a Director at Arturus Capital Ltd.
from 2004 to 2007.
Nair holds a doctorate degree from the Australian National University.
Anciens postes connus de Chenicheri Hariharan Nair
| Sociétés | Poste | Fin |
|---|---|---|
| MEMPHASYS | President | 01/12/2012 |
Arturus Capital Ltd.
 Arturus Capital Ltd. Financial ConglomeratesFinance Arturus Capital Ltd. is an investment company that holds interests in mining and gas projects. The company was founded on May 31, 1972 and is headquartered in North Perth, Australia. | Directeur/Membre du Conseil | 22/12/2007 |
PrIME Biologics Pte Ltd.
 PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Président | - |
Formation de Chenicheri Hariharan Nair
| Australian National University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEMPHASYS | Health Technology |
| Entreprise privées | 2 |
|---|---|
Arturus Capital Ltd.
Arturus Capital Ltd. Financial ConglomeratesFinance Arturus Capital Ltd. is an investment company that holds interests in mining and gas projects. The company was founded on May 31, 1972 and is headquartered in North Perth, Australia. | Finance |
PrIME Biologics Pte Ltd.
PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Health Technology |
